VYGR icon

Voyager Therapeutics
VYGR

Overview Fund Activity

107 hedge funds and large institutions have $230M invested in Voyager Therapeutics in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
-3
Holders Change %
-2.73%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
32
Reduced
30
Closed
23
Calls
$386K
Puts
$200K
Net Calls
+$186K
Net Calls Change
+$566K

Top Buyers

1
AQR Capital Management
1
AQR Capital Management
Connecticut
$5.4M
2
Morgan Stanley
2
Morgan Stanley
New York
$4.11M
3
BCM
3
Bridgeway Capital Management
Texas
$1.53M
4
AACP
4
Advantage Alpha Capital Partners
California
$1.49M
5
BlackRock
5
BlackRock
New York
$22.2M

Top Sellers

1
HIM
1
Hillsdale Investment Management
Ontario, Canada
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$1.55M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$3.43M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$3.53M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$8.48M
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
126
Simplex Trading
Illinois
– -$58K -7,572 Closed
GCM
127
Gladius Capital Management
Illinois
– -$24.7K -3,182 Closed
CA
128
Clearstead Advisors
Ohio
– -$388 -50 Closed
PA
129
Parallel Advisors
California
– -$380 -49 Closed
OIA
130
Optimum Investment Advisors
Illinois
– -$333 -43 Closed
2 3 4 5
6